{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPHLDA1 (also known as TDAG51) is emerging as a multifaceted regulator of cell fate, with its expression tightly modulated in a context‐dependent manner in cancer. In melanocytic lesions, high PHLDA1 expression is characteristic of benign nevi, whereas its progressive loss in primary and metastatic melanoma is linked to diminished apoptosis and enhanced tumor cell survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In fibroblasts overexpressing the IGF‐I receptor, IGF‐I triggers PHLDA1 expression via the p38 MAPK pathway, mediating anti‐apoptotic signals."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In breast cancer, reduced PHLDA1 mRNA and protein levels are strongly associated with poor patient outcomes, and its expression is upregulated by 17β‐estradiol acting through the estrogen receptor."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, as a direct target of p53, PHLDA1 participates in the repression of Akt signaling and contributes to p53‐mediated apoptosis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", with re‐expression studies in cervical cancer cells further underscoring its role in cell death regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn other cancer types, PHLDA1 exerts additional, sometimes contrasting, functions. In the human intestine, discrete expression of PHLDA1 in crypt base and +4 cells supports its role as a putative epithelial stem cell marker"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while its diagnostic utility is demonstrated in distinguishing cutaneous adnexal neoplasms."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " In neuroblastoma, therapeutic interventions that induce PHLDA1 (together with p53) are associated with increased apoptosis, whereas shRNA‐mediated knockdown results in enhanced mitochondrial potential, increased Aurora A and Akt signaling and reduced caspase activation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "15"}]}, {"type": "t", "text": " In colon cancer, PHLDA1 supports cell migration and anchorage‐independent growth via regulation of integrin expression, while its ability to modulate receptor tyrosine kinase signaling is highlighted by its direct interaction with ErbB3 that limits ErbB2/ErbB3 complex formation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": " Furthermore, downregulation of PHLDA1 has been implicated in the acquisition of resistance to RTK‐targeted therapies"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", and studies in neuroblastoma also reveal that delayed autophagy—linked to altered PHLDA1 levels—contributes to resistance to apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Finally, in aggressive brain tumors, PHLDA1 can promote cell proliferation by enhancing Ras/Raf/Mek/Erk signaling, while upregulation of PHLDA1 is also observed in mutant KRAS‐driven colorectal cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in oncogenesis, PHLDA1/TDAG51 is involved in several non‐malignant cellular processes. In T lymphocytes, studies of its promoter architecture have revealed a bidirectional organization that governs its expression during activation, although its induction does not directly correlate with activation‐induced cell death."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " Elevated TDAG51 expression in the anterior temporal neocortex of patients with intractable epilepsy further hints at roles in neural pathophysiology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Moreover, in the vascular system and liver, modulation of TDAG51 influences metabolic and structural homeostasis; for instance, reduced hepatic TDAG51 levels are associated with nonalcoholic fatty liver disease and insulin resistance, while its deficiency has been linked to pathogenic vascular calcification in chronic kidney disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Rüdiger Neef, Martina A Kuske, Elma Pröls, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12384558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12384558"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yuka Toyoshima, Michael Karas, Shoshana Yakar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M400661200"}], "href": "https://doi.org/10.1074/jbc.M400661200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15037619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15037619"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Maria Aparecida Nagai, José Humberto T G Fregnani, Mário Mourão Netto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of PHLDA1 gene expression is associated with breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-006-9475-6"}], "href": "https://doi.org/10.1007/s10549-006-9475-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17211533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17211533"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "A C Marchiori, D A Casolari, M A Nagai "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Braz J Med Biol Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1590/s0100-879x2008005000029"}], "href": "https://doi.org/10.1590/s0100-879x2008005000029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18641796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18641796"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yu Chen, Masahiro Takikawa, Shuichi Tsutsumi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1, another PHLDA family protein that inhibits Akt."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13796"}], "href": "https://doi.org/10.1111/cas.13796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30207029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30207029"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Flavia R Mangone, Maira Av Valoyes, Renan G do Nascimento, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic and predictive value of Pleckstrin homology-like domain, family A family members in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomark Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/bmm-2020-0417"}], "href": "https://doi.org/10.2217/bmm-2020-0417"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33179538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33179538"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xuhong Song, Lulu Zhou, Wenrui Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-023-04752-w"}], "href": "https://doi.org/10.1007/s11010-023-04752-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37155089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37155089"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anuratha Sakthianandeswaren, Michael Christie, Carla D'Andreti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-2342"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-2342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21558389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21558389"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Klaus Sellheyer, Paula Nelson, Heinz Kutzner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cutan Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cup.12085"}], "href": "https://doi.org/10.1111/cup.12085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23398472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23398472"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Maxime Battistella, Bernard Peltre, Bernard Cribier "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Dermatopathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/DAD.0b013e31828a31ae"}], "href": "https://doi.org/10.1097/DAD.0b013e31828a31ae"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23719479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23719479"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Irena Horwacik, Małgorzata Durbas, Elżbieta Boratyn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2013.08.018"}], "href": "https://doi.org/10.1016/j.canlet.2013.08.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23962557"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23962557"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Takatoshi Murata, Tsutomu Sato, Takeshi Kamoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2013.10.023"}], "href": "https://doi.org/10.1016/j.yexcr.2013.10.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24270013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24270013"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "I Kastrati, E Canestrari, J Frasor "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.180"}], "href": "https://doi.org/10.1038/onc.2014.180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24954507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24954507"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Po Zhao, Yali Lu, Lin Liu "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26191222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26191222"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Małgorzata Durbas, Irena Horwacik, Elżbieta Boratyn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of Aurora A, TRKB and affects proteins involved in apoptosis and autophagy pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2016.3572"}], "href": "https://doi.org/10.3892/ijo.2016.3572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27278006"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27278006"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Shigeyuki Magi, Kazunari Iwamoto, Noriko Yumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.778399"}], "href": "https://doi.org/10.1074/jbc.M117.778399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29233889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29233889"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Abbie E Fearon, Edward P Carter, Natasha S Clayton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2018.02.028"}], "href": "https://doi.org/10.1016/j.celrep.2018.02.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29490281"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29490281"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Małgorzata Durbas, Paweł Pabisz, Katarzyna Wawak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Apoptosis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10495-018-1472-9"}], "href": "https://doi.org/10.1007/s10495-018-1472-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30027525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30027525"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Shumpei Ohnami, Kouji Maruyama, Kai Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-021-04172-8"}], "href": "https://doi.org/10.1007/s11010-021-04172-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33982211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33982211"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jiutao Wang, Ning Yao, Yamei Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-022-04538-1"}], "href": "https://doi.org/10.1007/s00018-022-04538-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36107262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36107262"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "H-H Oberg, B Sipos, H Kalthoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.cdd.4401407"}], "href": "https://doi.org/10.1038/sj.cdd.4401407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15002043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15002043"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Marc Meier-Noorden, Sven Flindt, Ulrich Kalinke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2004.05.006"}], "href": "https://doi.org/10.1016/j.gene.2004.05.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15315823"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15315823"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Zhi-qin Xi, Lin-yuan Wang, Ji-jun Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TDAG51 in the anterior temporal neocortex of patients with intractable epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2007.08.016"}], "href": "https://doi.org/10.1016/j.neulet.2007.08.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17870236"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17870236"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Khrystyna Platko, Paul F Lebeau, Gabriel Gyulay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.119.313779"}], "href": "https://doi.org/10.1161/ATVBAHA.119.313779"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32434409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32434409"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Tamana R Yousof, Celeste C Bouchard, Mihnea Alb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2024.105655"}], "href": "https://doi.org/10.1016/j.jbc.2024.105655"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38237682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38237682"}]}]}]}